Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

36.68
Delayed Data
As of Oct 20
 +0.37 / +1.02%
Today’s Change
29.83
Today|||52-Week Range
50.10
-18.99%
Year-to-Date
No recent news for Dr.Reddy's Laboratories Ltd.

Today’s Trading

Previous close36.31
Today’s open36.39
Day’s range36.37 - 36.80
Volume128,883
Average volume (3 months)333,908
Market cap$6.1B
Dividend yield0.86%
Data as of 4:02pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-39.73%
Earnings growth (this year)+15.76%
Earnings growth (next 5 years)+24.65%
Revenue growth (last year)-10.90%
P/E ratio0.5
Price/Sales3.19
Price/Book3.18

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA+0.17+0.79%
----
CTLTCatalent Inc+0.29+0.68%
UTHRUnited Therapeutics ...+1.95+1.64%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.27
Annual revenue (last year)$2.1B
Annual profit (last year)$179.6M
Net profit margin8.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts